Performance analysis of Niagen Bioscience (NAGE)
Annual Return
Over the past 3 years, NAGE has had an average annual return of +29.75%, outperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, NAGE has had an average annual return of -19.64%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, NAGE has had an average annual return of -1.45%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jul 15, 2008, NAGE has had an average annual return of -5.12%, underperforming the benchmark SPY, which returned +12.68% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -45.13% | +19.90% | +270.93% | -14.89% | -55.08% | -22.07% | +11.36% | +25.66% | -41.67% | +77.62% | -9.56% | +38.47% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||
| -42.04% | +186.76% | -3.60% | -59.56% | +209% | -62.38% | -61.00% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.82% | -15.70% | -12.67% | +7.27% | -18.40% | -17.37% | +9.42% | -45.13% | |||||
| 2025 | +6.14% | +0.18% | +22.34% | +13.76% | +37.84% | +33.18% | -35.11% | +5.88% | -5.75% | -19.19% | -10.22% | -6.05% | +19.90% |
| 2024 | +2.08% | +14.43% | +108.35% | +1.71% | -22.02% | -1.11% | +9.53% | +15.38% | +5.82% | -4.39% | +121.20% | -31.29% | +270.93% |
| 2023 | +16.66% | -14.78% | -8.41% | -13.71% | +6.82% | +11.30% | +9.58% | -7.54% | -8.21% | -9.56% | +5.25% | +2.91% | -14.89% |
| 2022 | -24.88% | -2.85% | -9.89% | -23.16% | +0.52% | -12.08% | +2.96% | -16.27% | -14.56% | +23.56% | +13.14% | -2.30% | -55.08% |
| 2021 | -1.24% | +193.87% | -32.95% | -4.92% | -6.54% | +18.80% | -11.87% | -1.84% | -26.49% | -1.28% | -24.24% | -20.25% | -22.07% |
| 2020 | +2.32% | -16.33% | -11.66% | +53.40% | -3.82% | -4.57% | +10.24% | -2.17% | -18.98% | +12.46% | +9.98% | -3.23% | +11.36% |
| 2019 | -2.91% | +4.81% | +20.06% | +6.19% | -10.56% | +16.85% | -0.45% | -15.55% | +0.64% | -26.56% | +25.94% | +18.42% | +25.66% |
| 2018 | -21.60% | +18.24% | -22.94% | -16.43% | -4.00% | +10.10% | +20.77% | +1.10% | -5.29% | -18.88% | +1.99% | -3.37% | -41.67% |
| 2017 | -16.01% | -0.71% | -2.54% | +15.62% | +5.44% | +16.47% | -9.68% | -2.61% | +27.99% | -4.90% | +69.21% | -15.03% | +77.62% |
Drawdown analysis of Niagen Bioscience (NAGE)
The maximum drawdown for the NAGE was -97.00%, occurring on Aug 3, 2009. Recovery took 2911 trading sessions.
The current NAGE drawdown is -81.38%.
Since Jul 15, 2008 NAGE has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 4 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.00% | Aug 19, 2008 | 239 | Aug 3, 2009 | 2911 | Feb 25, 2021 | 3150 |
| -93.65% | Feb 25, 2021 | 399 | Sep 26, 2022 | Ongoing | Ongoing | Ongoing |
| -25.00% | Jul 15, 2008 | 1 | Jul 16, 2008 | 4 | Jul 22, 2008 | 5 |
| -22.22% | Jul 22, 2008 | 19 | Aug 18, 2008 | 1 | Aug 19, 2008 | 20 |